A novel method to treat 'triple-negative' breast cancer has been identified by scientists. The treatment, which is based on two drugs that are already in use, is currently being tested on mice, but human trials are expected to start soon, News.com.au reported.
Triple-negative cancer affects about 15 percent of people with breast cancer and is particularly difficult to treat.
Breast Cancer - Prevention and Management with Lifestyle Changes
Lifestyle choices may or may not cause breast cancer but healthy lifestyle changes can open up avenues beyond breast cancer. Good habits will allow one to fight breast cancer and to live with dignity.
Advertisement
Professor Robert Baxter and his team at Sydney's Kolling Institute of Medical Research have discovered how a protein helps some breast cancers grow and become resistant to treatment.
They then combined two drugs to create a new treatment, which according to them, might be an effective way to stop tumour growth.
Baxter said that their tests have shown the drugs to be extremely effective when used together and they are now hoping to move on to further preclinical studies.
Source: ANI
Baxter said that their tests have shown the drugs to be extremely effective when used together and they are now hoping to move on to further preclinical studies.
Source: ANI
Researchers Successful In Treatment of Triple Negative Breast Cancer by Modulation of the OGF-OGFr Axis
A novel biological pathway, the OGF-OGFr axis, can be modulated in human triple-negative breast cancer cells to inhibit proliferation, discover researchers.
Advertisement
 Role of Testosterone in Triple Negative Breast Cancer Examined in Mayo Clinic-TGen StudyThere is hope that blocking a testosterone receptor might lead to a new way to treat an aggressive form of breast cancer. | Advertisement
|
Quiz on Breast Cancer
Breast cancer is one of the leading causes of cancer deaths among women. It is often said that a woman who breast-feeds is at a lower risk of developing cancer compared to another who does not .Are these mere old wives tales or is there some truth in it? This quiz on breast cancer has all the details.
Advertisement
Recommended Reading
Latest Cancer News
The approvals of pipeline drugs such as momelotinib and Vonjo for myelofibrosis (a rare type of blood cancer) over some time will handle the critical unmet needs.
New study highlights the dual role that blood vessels can play in cancer immunotherapy and eliciting anti-tumor immune responses or even preventing breast cancer spread.
New study evaluated the association between exposure to the chemical agent orange and the development of blood cancer with increased bleeding and blood clot formation.
Study suggests two-year immunotherapy treatment for advanced lung cancer may be reasonable
A ray of hope for glioma patients as targeted therapy boosts treatment duration.